Live Breaking News & Updates on Pharmabcine Inc

Stay updated with breaking news from Pharmabcine inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PharmAbcine Announces Positive Results for Its Novel TIE2-Activating Antibody in GLP Toxicology Study

/PRNewswire/ PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics,. ....

Daejeon , Taejon-gwangyoksi , South-korea , Quan-dong-nguyen , Jin-san-yoo , Pharmabcine-inc , Ir-pr-team , Youtube , Linkedin , Prnewswire-pharmabcine-inc , Business-development-team , Stanford-university

RNAGENE Signs a Collaborative Research Agreement with PharmAbcine to Develop Novel mRNA Therapeutics

RNAGene Inc., a South Korean biotech which specializes in the development of mRNA (messenger ribonucleic acid)-based therapeutics, announced today that it has signed a Collaborative ....

Seoul , Soult-ukpyolsi , South-korea , South-korean , Jin-san-yoo , Gil-lee , Pharmabcine-inc , Rnagene-inc , Youtube , Linkedin , Collaborative-research-agreement , Prnewswire-rnagene-inc

South Korea lays focus on novel mRNA therapeutics

NuclixBio announces a collaborative research agreement with ΒΈ ....

South-korea , South-korean , Pharmabcine-inc , Nuclixbio-inc , Nuclixbio , Nuclixbio , Rna , Research , Partnership ,